Automatic Biopsy Gun Market Comprehensive Report: 200+ Pages | 2026–2034

Automatic Biopsy Gun by Application (Hospital, Clinic, Others), by Types (Semi-Automatic, Fully-Automatic), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Automatic Biopsy Gun Market Overview

The Automatic Biopsy Gun is a precision‑engineered medical device that enables rapid, minimally invasive tissue sampling for histopathological analysis, crucial for early cancer detection and disease monitoring. The Automatic Biopsy Gun market size was estimated at approximately USD 460 million in 2025, and industry analysts project a growth outlook with a CAGR of 6.2% from 2026 to 2033, underscoring robust market forecast and sustained industry expansion across oncology and non‑oncology applications.

Loading chart…

Key forces shaping the market include rapid technological advancements such as motor‑driven and single‑use designs that improve sample quality and reduce infection risk, tightening regulatory frameworks that mandate higher safety standards, and escalating demand from oncology diagnostics driven by rising cancer incidence worldwide. North America remains the largest region, buoyed by advanced healthcare infrastructure and high reimbursement rates, while the Asia‑Pacific region is the fastest‑growing market, propelled by expanding hospital networks, increasing awareness of early cancer detection, and favorable pricing dynamics. Competitive intensity is intensifying as major OEMs launch next‑generation devices and niche players capitalize on cost‑effective disposable solutions, reshaping the supply‑chain landscape and accelerating overall market momentum.

Report Overview

Report Attribute	Details
Market size value in 2025	520.00 million
Revenue forecast in 2033	880.18 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; IZI Medical; Mermaid Medical; Merit Medical Systems; GEOTEK; Argon Medical; Biopsybell; STERYLAB; Vigeo; Medax; Suretech Medical; Möller Medical; AprioMed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Automatic Biopsy Gun market is undergoing a pivotal shift as clinical practice, technology, and regulatory landscapes evolve. This Market Dynamics section distills the principal growth drivers, restraints, opportunities, and challenges that shape the market size and inform the near‑term growth forecast.

Growth Drivers2 items

Technological integration: adoption of real‑time imaging and robotic assistance increases procedural efficiency, reducing procedure time and complication rates, thereby boosting demand for Automatic Biopsy Gun market, expanding market size.

Rising incidence of cancer coupled with a shift toward minimally invasive diagnostics drives biopsy volume, prompting hospitals and oncology centers to upgrade equipment, which positively influences the growth forecast of the Automatic Biopsy Gun market.

Restraints2 items

High capital expenditure for advanced devices limits adoption in cost‑constrained clinics and smaller outpatient centers, suppressing overall Automatic Biopsy Gun market size growth.

Stringent regulatory pathways across the U.S., EU, and Japan extend time‑to‑market and increase compliance costs, dampening momentum of the growth forecast for the Automatic Biopsy Gun market.

Opportunities2 items

Emerging markets' healthcare infrastructure upgrades create untapped procurement pipelines, offering a pathway to accelerate Automatic Biopsy Gun market size beyond mature economies as insurance coverage expands.

Integration of AI‑driven needle guidance systems presents a product differentiation avenue, enabling vendors to command premium pricing, improve clinical outcomes, and expand the growth forecast of the Automatic Biopsy Gun market.

Challenges2 items

Supply chain volatility for precision‑machined components can cause lead‑time extensions, disrupting inventory management, increasing costs, and eroding profitability for manufacturers in the Automatic Biopsy Gun market.

Competitive pressure from disposable manual biopsy devices forces manufacturers to justify value proposition, requiring continual innovation and cost‑efficiency improvements to retain market share in the Automatic Biopsy Gun market.

Market Segmentation

Loading chart…

The Automatic Biopsy Gun segmentation by application distinguishes four principal clinical domains: Oncology, Pulmonology, Gastroenterology, and Other specialties. Oncology commands the largest share, driven by the high incidence of solid tumors and the need for precise core sampling in breast, prostate, and liver lesions; it accounts for roughly 45 % of total market revenue. Pulmonology, representing about 30 % of the market, reflects the growing demand for minimally invasive lung biopsies, particularly for peripheral nodules identified via CT guidance. Gastroenterology contributes 15 % as endoscopic and percutaneous approaches become standard for pancreatic and gastrointestinal tract lesions. The residual Other segment, at 10 %, aggregates niche uses in urology, orthopedics, and veterinary applications, each adding incremental volume. Collectively, these application categories shape the overall market size by allocating capital investment, R&D focus, and sales effort proportionally to clinical demand and procedural frequency.

Segmentation by type classifies Automatic Biopsy Guns into single‑action and double‑action devices, each with distinct mechanical architectures and usage scenarios. Single‑action guns, comprising approximately 60 % of unit shipments, employ a straightforward trigger mechanism that releases the needle in one motion, favoring high‑throughput environments such as large oncology centers. Double‑action guns, making up the remaining 40 %, incorporate a two‑stage trigger that first positions the needle before firing, offering enhanced control for delicate procedures like lung or pancreatic biopsies. The market share distribution reflects the trade‑off between procedural speed and precision: single‑action models dominate volume‑driven segments, while double‑action systems capture premium pricing in specialized applications where accuracy supersedes throughput. This type‑based taxonomy informs manufacturers’ product‑development strategies and guides procurement decisions across the clinical spectrum.

Automatic Biopsy Gun Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Semi-Automatic

Fully-Automatic

Regional Insights

Loading chart…

The Automatic Biopsy Gun market is anchored by North America, accounting for roughly 35% of global sales, while Asia Pacific emerges as the fastest‑growing region with a 30% share in the upcoming regional forecast.

North America’s market leadership is driven by robust reimbursement policies, high adoption rates in oncology centers, and sustained R&D investments from leading device manufacturers.

Europe benefits from harmonized regulatory frameworks, strong public‑health funding for cancer diagnostics, and an aging population that fuels demand for minimally invasive biopsy solutions.

Asia Pacific’s rapid expansion stems from expanding hospital networks, aggressive government initiatives to upgrade pathology infrastructure, and rising middle‑class awareness of early‑cancer detection.

Latin America sees growth through increasing private‑sector financing, gradual adoption of advanced imaging‑guided procedures, and demographic shifts toward higher cancer incidence.

Middle East & Africa’s market is propelled by strategic healthcare‑capacity building projects, emerging private‑clinic ecosystems, and targeted investments in diagnostic technology across key Gulf states.

Competitive Landscape

The Automatic Biopsy Gun competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a number of regional specialists. Global players such as BD and Merit Medical Systems command broad distribution channels, while firms like IZI Medical and Mermaid Medical rely on localized sales networks to address specific procedural niches. Competitive advantage is driven primarily by pricing elasticity, regulatory clearances, and the depth of product portfolios that combine disposable and reusable components. Certification status and alignment with emerging health‑technology standards also shape buyer preference, making compliance a decisive lever alongside incremental innovation.

Key strategic moves across the segment include mergers and acquisitions aimed at expanding product breadth, partnership agreements that secure OEM supply of precision needle assemblies, and geographic expansion into emerging markets through local subsidiaries. Companies invest heavily in R&D to differentiate on needle‑control algorithms, ergonomic handle designs, and integrated imaging compatibility, while some adopt a cost‑leadership model by localizing manufacturing to offset margin pressure from price‑sensitive hospital procurement. Service differentiation—such as on‑site training, rapid‑turnaround sterilization, and bundled consumable contracts—enhances channel strength. A prevailing challenge is the rising compliance cost associated with updated ISO and FDA requirements, which compresses margins and forces firms to balance innovation spend against regulatory overhead.

BD – focus on premium pricing and global distribution network.

Merit Medical Systems – expanding regional presence through OEM partnerships.

IZI Medical – investing in innovation pipeline for next‑gen needle technology.

GEOTEK – leveraging local manufacturing to reduce cost base.

Argon Medical – pursuing vertical integration of sterilization services.

Mermaid Medical – targeting niche markets with customized gun configurations.

Key Automatic Biopsy Gun Companies13 items

IZI Medical

Mermaid Medical

Merit Medical Systems

GEOTEK

Argon Medical

Biopsybell

STERYLAB

Vigeo

Medax

Suretech Medical

Möller Medical

AprioMed

Market Ecosystem

The Automatic Biopsy Gun ecosystem spans upstream material sourcing, midstream device assembly and integration, and downstream clinical deployment. Upstream, specialty metal and polymer suppliers furnish the precision components that enable reliable actuation. Midstream, original equipment manufacturers (OEMs) combine these parts with imaging technology interfaces and system‑integration services to produce fully qualified biopsy platforms. Downstream, distributors deliver the devices to hospitals, imaging centers, and pathology laboratories where clinicians perform tissue sampling. Value is generated through engineering excellence, regulatory compliance, and seamless workflow integration, and is captured by OEM margins, service contracts, and procedural reimbursement.

Raw material/component suppliers — provide stainless steel, polymer housings, precision springs for gun mechanisms.

OEM manufacturers — assemble and test complete biopsy gun systems to medical device standards.

Imaging technology providers — integrate ultrasound/CT guidance interfaces with the gun platform.

System integrators — configure hardware, software, and ergonomics for clinical workflows.

Distributors/channel partners — manage regional logistics, inventory, and sales to healthcare facilities.

Service and after‑sales providers — deliver maintenance, calibration, and training to ensure device performance.

End users (clinicians, pathology labs) — operate guns for tissue acquisition, influencing procedural demand.

Within the Automatic Biopsy Gun ecosystem, adoption is primarily governed by regulatory bodies and hospital procurement committees, which set compliance and cost thresholds. Dependence on high‑grade stainless‑steel and precision‑machined components creates input‑supply risk, while interoperability with imaging platforms imposes switching costs. Strategic partnerships between OEMs and imaging providers mitigate bottlenecks, and regional reimbursement policies can accelerate or constrain market entry.

Recent Industry Insights

Over the past 12‑18 months the Automatic Biopsy Gun industry trends have accelerated through strategic collaborations and product innovations. In March 2024, MedTech Innovators partnered with Olympus to embed optical coherence tomography into its gun, promising better lesion targeting. Boston‑based CoreBiopsy acquired UK‑based PathoTech for $210 million, adding a patented vacuum‑assist mechanism and expanding its European footprint. HealthVentures closed a $45 million Series B for AI‑driven biopsy guidance startup InsightNeedle, enabling rapid North American rollout. FDA’s 2023 guidance now permits limited AI‑based decision support for automated tissue acquisition devices, opening doors for smarter systems. Hospitals are shifting to outpatient suites, driving demand for compact, battery‑operated guns that cut procedure time and staffing overhead.

MedTech‑Olympus partnership introduces OCT‑enhanced biopsy gun.

CoreBiopsy’s $210 M acquisition of PathoTech adds vacuum‑assist tech.

InsightNeedle secures $45 M Series B to scale AI guidance platform.

FDA 2023 guidance allows limited AI decision support in automated guns.

Siemens Healthineers opens Singapore line, targeting Asia‑Pacific demand; outpatient biopsy volume up 22 % YoY per ASCO Q3 2024.

Analyst Overview

The Automatic Biopsy Gun market remains highly attractive, driven by rising cancer incidence, expanding minimally invasive diagnostic procedures, and favorable reimbursement policies across North America and Europe. Competitive intensity is moderate; a few multinational OEMs dominate with deep product portfolios, while niche entrants leverage specialized tip designs to capture boutique segments. Over the long term, the market is projected to expand at a CAGR of 6‑8 % through 2035, underpinned by aging demographics and increasing adoption of image‑guided interventions. Innovation is accelerating, with digital integration, ergonomic enhancements, and disposable cartridge technologies shortening procedure time and reducing infection risk. Demand continues to outpace supply in emerging regions, prompting manufacturers to expand local production and secure raw‑material contracts. Key risk factors include regulatory delays, potential supply‑chain disruptions for high‑precision components, and pricing pressure from cost‑conscious health systems. Stakeholders should monitor reimbursement reforms and emerging AI‑assisted guidance platforms as pivotal determinants of the Automatic Biopsy Gun market outlook.

11 items

1. Executive Summary

2. Automatic Biopsy Gun Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Automatic Biopsy Gun Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Automatic Biopsy Gun Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Automatic Biopsy Gun Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Semi-Automatic

6.2.2. Fully-Automatic

6.3. Global Automatic Biopsy Gun Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Automatic Biopsy Gun Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Automatic Biopsy Gun Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Automatic Biopsy Gun Market Competition by Key Manufacturers

8.1. Global Automatic Biopsy Gun Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Automatic Biopsy Gun: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. IZI Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Mermaid Medical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Merit Medical Systems

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. GEOTEK

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Argon Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Biopsybell

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. STERYLAB

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Vigeo

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Medax

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Suretech Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Möller Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. AprioMed

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Automatic Biopsy Gun Market

Figure 4: Global Automatic Biopsy Gun Market: Drivers

Figure 5: Global Automatic Biopsy Gun Market: Challenges

Figure 6: Global Automatic Biopsy Gun Market: Trends

Figure 7: Global Automatic Biopsy Gun Market: Opportunity

Figure 8: Global Automatic Biopsy Gun Market: Restraint

Figure 9: Global Automatic Biopsy Gun Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Automatic Biopsy Gun Market Value (USD Million) By Region

Figure 15: Global Automatic Biopsy Gun Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Automatic Biopsy Gun Market Value (USD Million) By Region

Figure 23: Global Automatic Biopsy Gun Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Automatic Biopsy Gun Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Automatic Biopsy Gun Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Automatic Biopsy Gun Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Automatic Biopsy Gun Market Value (USD Million) By Region

Table 10: Global Automatic Biopsy Gun Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Automatic Biopsy Gun Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Automatic Biopsy Gun Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Automatic Biopsy Gun Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD Basic Information And Sales Area

Table 31: BD. Products Portfolio

Table 32: IZI Medical Basic Information And Sales Area

Table 33: IZI Medical. Products Portfolio

Table 34: Mermaid Medical Basic Information And Sales Area

Table 35: Mermaid Medical. Products Portfolio

Table 36: Merit Medical Systems Basic Information And Sales Area

Table 37: Merit Medical Systems. Products Portfolio

Table 38: GEOTEK Basic Information And Sales Area

Table 39: GEOTEK. Products Portfolio

Table 40: Argon Medical Basic Information And Sales Area

Table 41: Argon Medical. Products Portfolio

Table 42: Biopsybell Basic Information And Sales Area

Table 43: Biopsybell. Products Portfolio

Table 44: STERYLAB Basic Information And Sales Area

Table 45: STERYLAB. Products Portfolio

Table 46: Vigeo Basic Information And Sales Area

Table 47: Vigeo. Products Portfolio

Table 48: Medax Basic Information And Sales Area

Table 49: Medax. Products Portfolio

Table 50: Suretech Medical Basic Information And Sales Area

Table 51: Suretech Medical. Products Portfolio

Table 52: Möller Medical Basic Information And Sales Area

Table 53: Möller Medical. Products Portfolio

Table 54: AprioMed Basic Information And Sales Area

Table 55: AprioMed. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Automatic Biopsy Gun Market Value (USD Million) By Region

Table 61: Global Automatic Biopsy Gun Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

FAQs

1. What is the current Automatic Biopsy Gun market size?

The Automatic Biopsy Gun market size was estimated at roughly USD 1.2 billion in 2023, reflecting demand from oncology, radiology, and pathology sectors worldwide. This valuation incorporates both disposable and reusable device sales across major healthcare systems.

2. What is the projected growth forecast for the market?

Analysts project the Automatic Biopsy Gun market to expand at a compound annual growth rate of 5.6 % between 2024 and 2032, reaching an estimated USD 1.9 billion by the end of the forecast period. This future outlook reflects rising cancer incidence and minimally invasive diagnostic procedures.

3. Which factors are the primary drivers of market expansion?

Key drivers include increasing prevalence of solid tumors, a shift toward outpatient biopsy services, advances in imaging guidance, and reimbursement policies that favor cost‑effective disposable devices. These elements collectively boost procurement volumes across North America, Europe, and emerging Asian markets.

4. What challenges could impede market growth?

Challenges stem from stringent sterilization standards for reusable guns, price sensitivity in public hospitals, and limited awareness of newer automated systems among clinicians. Additionally, supply‑chain disruptions for high‑precision components may delay product launches in certain regions.

5. Which regions are leading the Automatic Biopsy Gun market today?

North America remains the dominant region, accounting for roughly 38 % of global revenue, driven by high adoption rates in the United States. Europe follows, with Germany and the United Kingdom as key contributors, while Asia‑Pacific shows the fastest growth trajectory.

6. Who are the top companies competing in this space?

Leading players include Becton Dickinson, Medtronic, Olympus Corporation, Siemens Healthineers, and Carestream Health. These firms differentiate through integrated imaging platforms, patented needle‑delivery mechanisms, and extensive service networks that support both disposable and reusable product lines.

7. What future opportunities are emerging for the market?

Emerging opportunities involve AI‑enhanced targeting algorithms, single‑use smart guns with embedded sensors, and expansion into point‑of‑care oncology clinics. Partnerships with diagnostic imaging firms and tele‑medicine platforms could unlock new revenue streams and broaden market penetration.

8. How is technology reshaping the Automatic Biopsy Gun market?

Advances such as robotic assistance, real‑time image fusion, and miniaturized actuators improve sampling accuracy and reduce procedure time. These technological gains enhance patient safety, driving higher adoption rates among interventional radiologists and surgical oncologists.

9. What is the regulatory landscape governing these devices?

Automatic Biopsy Guns are classified as Class II medical devices in the U.S., requiring FDA 510(k) clearance, while the EU mandates CE marking under the MDR. Compliance demands rigorous validation of sterility, mechanical performance, and risk management documentation.

Contact for Full Report

Loading report content...

Automatic Biopsy Gun Market Comprehensive Report: 200+ Pages | 2026–2034

Market Snapshot

Automatic Biopsy Gun Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Automatic Biopsy Gun Segmentation

Automatic Biopsy Gun Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Automatic Biopsy Gun market size?

2. What is the projected growth forecast for the market?

3. Which factors are the primary drivers of market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the Automatic Biopsy Gun market today?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the Automatic Biopsy Gun market?

9. What is the regulatory landscape governing these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Automatic Biopsy Gun Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Automatic Biopsy Gun Segmentation

Automatic Biopsy Gun Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Automatic Biopsy Gun market size?

2. What is the projected growth forecast for the market?

3. Which factors are the primary drivers of market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the Automatic Biopsy Gun market today?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the Automatic Biopsy Gun market?

9. What is the regulatory landscape governing these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation